GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenith Capital Corp (OTCPK:ZHCLF) » Definitions » Inventories, Raw Materials & Components

Zenith Capital (Zenith Capital) Inventories, Raw Materials & Components : $0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Zenith Capital Inventories, Raw Materials & Components?

Zenith Capital's inventories, raw materials & components for the quarter that ended in . 20 was $0.00 Mil.


Zenith Capital Inventories, Raw Materials & Components Historical Data

The historical data trend for Zenith Capital's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenith Capital Inventories, Raw Materials & Components Chart

Zenith Capital Annual Data
Trend
Inventories, Raw Materials & Components

Zenith Capital Quarterly Data
Inventories, Raw Materials & Components

Zenith Capital Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Zenith Capital (Zenith Capital) Business Description

Industry
Traded in Other Exchanges
N/A
Address
300, 4820 RIchard Road SW, Calgary, AB, CAN, T3E 6L1
Website
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.

Zenith Capital (Zenith Capital) Headlines

No Headlines